Drug intelligence / Profile preview

moxidectin

Development stage
Approved
Lead developer
Medicines Development for Global Health
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Oral (humans), Oral (veterinary), Topical (veterinary), Injectable/subcutaneous (veterinary)
01

Overview

Moxidectin is a broad-spectrum anthelmintic and endectocide used in both humans and animals. In humans, it is approved for the treatment of onchocerciasis (river blindness) caused by the parasitic worm Onchocerca volvulus. It works by selectively binding to glutamate-gated chloride ion channels and GABA-A gated chloride channels in the parasite's nerve and muscle cells. This increases membrane permeability to chloride ions, resulting in flaccid paralysis and death of microfilariae but does not kill adult worms. In veterinary medicine, moxidectin is widely used for prevention or control of internal and external parasites such as heartworm in dogs (including as part of combination products), gastrointestinal nematodes in cattle/sheep/horses/dogs/cats/wombats, sarcoptic mange (in combination with imidacloprid), stomach bots in horses, lungworm in cattle/sheep/horses/dogs/cats/wombats[1][2][5][9].

Brand names
ProHeart 6ProHeart6ProHeart-6Advantage MultiCoraxis
Other names
MoxidectinaMoxidectineMoxidectinum
02

Targets

GluCl (Glutamate-gated chloride channel)GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on moxidectin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on moxidectin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call